Acrux heads to the Finnish

By Dylan Bushell-Embling
Thursday, 14 August, 2008

Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.

Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.

Acrux retains the rights to supply the products to licensees in all territories.

Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.

Related News

NSW Govt delivers foot-and-mouth vaccine to protect livestock

A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...

Scientists optimise delivery of mRNA to target cells

A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...

'Anti-reward' brain network helps explain cocaine addiction

A new study identifies a specific 'anti-reward' network deep in the brain that undergoes...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd